In addition to its general function in initiating translation, the amplification and elevation of EIF3H have been observed in various malignancies, such as breast cancer, lung cancer, prostate cancer, esophageal carcinoma, and also HCC [18–22]. Here, EIF3H is linked to hepatocellular carcinoma.